CIK 0001819133
- Non-accelerated filer
- Smaller reporting company
Tango Therapeutics, Inc.
Sign in to watch- Ticker
- TNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-320-4900
- Business address
- 201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
- Former names
- BCTG Acquisition Corp.
- 4 Grant or award Director acquired 6,250 shares (grant or award)
- 4 Grant or award Director acquired 6,250 shares (grant or award)
- 4 Grant or award Director acquired 6,250 shares (grant or award)
- 4 Grant or award Director acquired 6,250 shares (grant or award)
- 4 Open-market sale General Counsel sold 5,330 shares at an average $3.07 ($16,369)
- 4 Open-market sale Chief Financial Officer sold 8,232 shares at an average $3.07 ($25,282)
- 4 Open-market sale Crystal Adam sold 14,283 shares at an average $3.07 ($43,866)
- 4 Open-market sale Chief Executive Officer sold 18,791 shares at an average $3.07 ($57,710)
- 4 Grant or award Chief Financial Officer acquired 26,119 shares (grant or award)
- 4 Grant or award Crystal Adam acquired 53,015 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 105,875 shares (grant or award)
- 4 Grant or award General Counsel acquired 27,363 shares (grant or award)
- 4 Open-market buy Director bought 20,000 shares at an average $3.70 ($74,000)
- 4 Open-market sale 10% owner sold 2,700,000 shares at an average $3.12 ($8,435,743)
- 4 Open-market sale Boxer Capital Management, LLC sold 3,080,000 shares at $3.14 ($9,671,200)
- 4 Open-market sale Boxer Capital Management, LLC sold 633,000 shares at $6.87 ($4,348,710)
- 4 Open-market sale Boxer Capital Management, LLC sold 875,000 shares at an average $6.97 ($6,101,250)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 67,400 shares at $10.53 ($709,756)
- 4 Open-market sale 10% owner sold 75,000 shares at $11.56 ($867,135)
Page 3 of 8 · 156 filings